Cambridge Investment Research Advisors
ALFA

Cambridge Investment Research Advisors’s AlphaClone Alternative Alpha ETF ALFA Stock Holding History

Cambridge Investment Research Advisors’s Portfolio ALFA Stock Details ALFA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q1 		– Sell
-5,355
Closed -$201K – 1697
2015
Q4 		$201K Sell
5,355
-9,374
-64% -$357K ﹤0.01% 1371
2015
Q3 		$594K Buy
14,729
+2,943
+25% +$130K 0.02% 680
2015
Q2 		$531K Buy
+11,786
New +$539K 0.01% 782

Other funds holding ALFA

UBS Group
UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $432B AUM 30.22% 1-Year Est. Return
MFS
Madrona Financial Services Everett, Washington $543M AUM 30.87% 1-Year Est. Return
TNBTD
Trustmark National Bank Trust Department Jackson, Mississippi $1.56B AUM 16.53% 1-Year Est. Return
Susquehanna International Group
Susquehanna International Group Bala Cynwyd, Pennsylvania $893B AUM 36.07% 1-Year Est. Return
VKH
Virtu KCG Holdings New York $3.6B AUM 19.31% 1-Year Est. Return
WA
WFG Advisors Dallas, Texas $442M AUM 31.93% 1-Year Est. Return
ACP
Arcus Capital Partners Atlanta, Georgia $278M AUM 14.53% 1-Year Est. Return
Envestnet Asset Management
Envestnet Asset Management Chicago, Illinois $424B AUM 22.96% 1-Year Est. Return
RJA
Raymond James & Associates St Petersburg, Florida $164B AUM 33.91% 1-Year Est. Return

Cambridge Investment Research Advisors's ALFA Position: Q1 2016 in Review

Cambridge Investment Research Advisors sold out of AlphaClone Alternative Alpha ETF (ALFA) in Q1 2016, closing a stake of 5,355 shares — an estimated $201K sold.

Cambridge Investment Research Advisors first reported a position in ALFA in Q2 2015 and held it in 3 quarters. The position peaked at $594K in Q3 2015. 26 funds tracked by Wall St. Rank hold ALFA as of Q1 2016.

  • Cambridge Investment Research Advisors reported no remaining AlphaClone Alternative Alpha ETF position as of Q1 2016 after selling out during the quarter.
  • Cambridge Investment Research Advisors sold 5,355 AlphaClone Alternative Alpha ETF shares in Q1 2016, an estimated $201K.
  • Cambridge Investment Research Advisors first reported a position in AlphaClone Alternative Alpha ETF in Q2 2015 and held it in 3 quarters.
  • Cambridge Investment Research Advisors's AlphaClone Alternative Alpha ETF position peaked at $594K in Q3 2015.
  • 26 funds tracked by Wall St. Rank held AlphaClone Alternative Alpha ETF as of Q1 2016.

Based on Cambridge Investment Research Advisors's 13F filing for Q1 2016, filed 3 May 2016.